Trials / Completed
CompletedNCT03659461
Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes Mellitus
Comparative Study of Incretin System in Three Ethnic Groups With Abnormal Glucose Tolerance
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 174 (actual)
- Sponsor
- National University of Malaysia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is conducted to examine GLP-1, insulin resistance and insulin sensitivity portfolio in Malay, Chinese and Indian populations in Malaysia and to study the effect of DPPIV inhibitor in T2DM patients with different GLP-levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sitagliptin | oral 100mg Sitagliptin daily will be given for 12 weeks. Subjects are required to undergo OGTT pre and post treatment. |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2019-12-31
- Completion
- 2020-01-31
- First posted
- 2018-09-06
- Last updated
- 2022-03-15
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT03659461. Inclusion in this directory is not an endorsement.